FDA Adverse Event Injury Summary report: N

STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 30, FIRM

MDR report key: 14457481 · Received May 20, 2022

Report

Report Number
1000306051-2022-00095
Event Type
Injury
Date Received
May 20, 2022
Date of Event
March 11, 2021
Report Date
May 19, 2022
Product Code
FTM
UDI-DI
00818410010393
PMA / PMN Number
K070560
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

INTERNAL INVESTIGATION INTO STRATTICE LOT SP100368 INCLUDED A REVIEW OF THE REPORTED INFORMATION, REVIEW OF THE DEVICE HISTORY RECORDS, AND A REVIEW OF THE COMPLAINT HISTORY RECORDS. THE INVESTIGATION RESULTED IN NO REMARKABLE FINDINGS, INCLUDING NO OTHER COMPLAINTS REPORTED AGAINST THE LOT AND NO DEVIATIONS OR RELATED NON-CONFORMANCE'S REVEALED DURING PROCESSING. THE LOT WAS TERMINALLY STERILIZED WITHIN THE PROCESS PARAMETERS AND MET ALL QC RELEASE CRITERIA. (B)(4). BASED ON OUR INTERNAL REVIEW WITH NO REMARKABLE FINDINGS, A RELATIONSHIP BETWEEN THE STRATTICE AND THIS EVENT COULD NOT BE DETERMINED. NO FURTHER ACTIONS ARE REQUIRED AS A NONCONFORMANCE COULD NOT BE CONFIRMED.

Description of Event or Problem · 0

IT WAS REPORTED THROUGH A LEGAL EVENT THAT A (B)(6) MALE PATIENT UNDERWENT HERNIA REPAIR SURGERY ON OR ABOUT (B)(6) 2016. DURING THE HERNIA REPAIR SURGERY, THE SURGEON IMPLANTED A STRATTICE RECONSTRUCTIVE TISSUE MATRIX ITEM 2030002, LOT SP100368 MESH IN HIM. AFTER SURGERY, 5 YEARS LATER, THE PATIENT HAD A REVISION SURGERY ON (B)(6) 2021.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1520194 STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 30, FIRM MESH, SURGICAL FTM SP100368 00818410010393

Patients

Seq Age Sex Outcome Treatment
1 52 YR Male Required Intervention NO INFORMATION REPORTED